{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:08:10Z","timestamp":1788354490468,"version":"build-2803163510"},"reference-count":40,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1636,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1471-0528.2011.02920.x","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T14:06:19Z","timestamp":1299765979000},"page":"814-824","source":"Crossref","is-referenced-by-count":119,"title":["Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status"],"prefix":"10.1111","volume":"118","author":[{"given":"R","family":"Manchanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abdelraheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AN","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Brunell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Burnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Side","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Saridogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Oram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,10]]},"reference":[{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.ejhg.5201256","article-title":"Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1\/2 mutations","volume":"12","author":"Marroni","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008469-200508000-00008","article-title":"Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel","volume":"14","author":"Rennert","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","article-title":"Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations","volume":"108","author":"Schmeler","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","article-title":"Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer","volume":"97","author":"Meeuwissen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejca.2005.11.020","article-title":"Risk-reducing surgery in women with familial susceptibility for breast and\/or ovarian cancer","volume":"42","author":"Antill","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0004.2006.00665.x","article-title":"Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"70","author":"Phillips","year":"2006","journal-title":"Clin Genet"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0022-5347(01)61797-X","article-title":"Laparoscopic bowel injury: incidence and clinical presentation","volume":"161","author":"Bishoff","year":"1999","journal-title":"J Urol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1055-9965.1989.13.12","article-title":"Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation","volume":"13","author":"Wainberg","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB37|cit37","unstructured":"CRUK CancerStats, ovarian cancer UK 2004 http:\/\/www.publications.cancerresearchuk.org\/WebRoot\/crukstoredb\/CRUK_PDFs\/CSOV04.pdf"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome","volume":"113","author":"ACOG","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1471-0528.2011.02920.x-BIB40|cit40","volume-title":"Familial Breast Cancer: The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care","author":"NICE","year":"2006"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2011.02920.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1471-0528.2011.02920.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:52:22Z","timestamp":1685987542000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2011.02920.x"}},"subtitle":["RRSO outcomes in BRCA and unknown mutation status women"],"short-title":[],"issued":{"date-parts":[[2011,3,10]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2011.02920.x","relation":{},"ISSN":["1470-0328"],"issn-type":[{"value":"1470-0328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,10]]}}}